肝肿瘤放疗定位:DCE-CT与4D-CT对比噪声比比较
本研究比较了15例患者共18个肝内病灶在动态增强CT与呼吸追踪4D-CT上的对比噪声比。结果显示DCE-CT图像组的CNR高于4D-CT,且在转移性、小于平均尺寸及既往治疗过的病灶中改善更显著。DCE-CT或有助于放疗靶区勾画。
要点
- DCE-CT在肝转移瘤的CNR显著优于4D-CT,可用于提高靶区勾画准确性
- 对于小于5.7 cm或既往治疗过的病灶,DCE-CT的CNR优势更明显
- 使用DCE-CT需考虑含碘对比剂使用及额外CT辐射剂量
核心结论
- DCE-CT图像组的对比噪声比(CNR)高于4D-CT图像组
- CNR改善在转移性病灶、小于平均尺寸5.7 cm的病灶及既往治疗过的病灶中具有显著性
- DCE-CT联合4D-CT在勾画小、既往治疗过的转移性肿瘤方面具有优势
研究设计与样本
- 本研究纳入15例患者共18个肝内病灶,其中8例为原发性肝细胞癌患者,7例为转移患者共10个肿瘤
- 所有病例均接受DCE-CT和呼吸追踪4D-CT检查
- 4D-CT和DCE-CT均采用120 kVp,管电流分别设置为600 mAs和1920 mAs
- 对每个病灶在每组图像上计算CNR,并使用配对t检验进行比较
关键影像表现/征象
- DCE-CT图像组的肝肿瘤病灶对比噪声比高于4D-CT图像组
诊断标准与关键数值
- 采用配对t检验比较DCE-CT与4D-CT的CNR差异
- 对照条件为4D-CT,即当前放疗计划的标准图像集
临床应用与阅片要点
- 在肝转移瘤放疗靶区勾画中,DCE-CT可作为4D-CT的补充以提高病灶显示
- 小病灶、既往治疗过的病灶及转移性病灶可能从DCE-CT联合4D-CT中获益更多
- 应用DCE-CT时需评估含碘对比剂使用风险及CT剂量增加的问题
局限性
- 样本量为15例患者共18个病灶,样本量较小
- 研究未报告多中心设计,推定为单中心研究
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We compare the contrast-to-noise ratio (CNR) of tumors on 4D-CT and DCE-CT and explore how DCE-CT can be used to enhance tumor delineation for radiotherapy targeting.
METHODS: A total of 18 intrahepatic lesions from 15 patients were included in this study. Eight patients with primary hepatocellular carcinoma, and 7 metastatic patients with a total of 10 tumors, underwent DCE-CT and respiration-tracked 4D-CT. Both 4D-CT and DCE-CT were acquired at 120 kVp, but with 600 and 1920 mAs, respectively. CNRs were calculated for each lesion in each image set and compared using a paired t-test.
RESULTS: DCE-CT image sets had CNRs that were higher than those of 4D-CT image sets. The improvement in CNR was significant for lesions that were metastatic rather than primary, for lesions that were smaller than the mean size (5.7 cm), and for lesions that had undergone prior treatment rather than those that had not.
CONCLUSIONS: Target volume delineation in liver radiotherapy is challenging due to the inherent low tumor CNR. DCE-CT significantly improves CNR in liver metastases compared to 4D-CT, the current standard for radiation treatment planning. Considerations for DCE-CT include patients with metastatic lesions, additional iodinated contrast, and CT dose.
ADVANCES IN KNOWLEDGE: DCE-CT combined with 4D-CT can offer advantages in delineating small, previously-treated metastatic tumors for radiotherapy.
引用
- Yang, Jensen, Beech, et al. A comparison of contrast-to-noise ratio of liver tumors between dynamic contrast-enhanced CT and respiration-tracked 4D-CT for radiotherapy targeting. Br J Radiol. 2026. PMID: 42241227. doi:10.1093/bjr/tqag132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。